Applied Clinical Trials
May 01, 2018
News
27
5
BMS executive shares his perspectives on the current biomarker landscape, the role of translational medicine in accelerating this area of study, and how BMS is working to advance biomarker research across their R&D portfolio.
May 01, 2018
News
27
5
Jill Wechsler interviews FDA Commissioner Scott Gottlieb about his push for more efficient R&D to help lower drug prices.
May 01, 2018
News
27
5
Peter O’Donnell explores potential parallels of the U.S. “right-to-try” debate in Europe.
May 01, 2018
From the Editor
27
5
May includes a number of events to get more visibility for clinical trial awareness, and to offer it as a care option.
May 01, 2018
Feature Article
27
5
Examining the unique standards and related challenges when assessing the safety and efficacy of cancer immunotherapy candidates.
May 01, 2018
CISCRP Corner
27
5
The third in a series of results from the Center for Information and Study on Clinical Research Participation’s (CISCRP) landmark 2017 Perceptions & Insights Study.
May 01, 2018
Issue PDF
27
5
Click the title above to open the Applied Clinical Trials May 2018 issue in an interactive PDF format.
March 31, 2018
A Closing Thought
27
5
Though digital technology has improved the R&D process, when it comes to important clinical benefits and outcomes, modern biotech products have rarely shown the advantages of older generations of drugs.
March 09, 2018
Feature Article
27
5
With technology’s increasing ability to gather and analyze previously unmanageable data sets, and medicine’s forays into genomics and targeted therapies, the time of the master protocol may be at hand.